US Stock MarketDetailed Quotes

Sensei Biotherapeutics (SNSE)

Watchlist
  • 30.490
  • +1.270+4.35%
Close Apr 17 16:00 ET
  • 30.390
  • -0.100-0.33%
Post 20:01 ET
40.87MMarket Cap-1.82P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Sensei Biotherapeutics (SNSE) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
17.09%-20.45M
33.29%-3.86M
34.44%-3.59M
-2.02%-5.91M
6.85%-7.09M
22.96%-24.67M
6.02%-5.79M
-17.36%-5.47M
38.79%-5.79M
35.11%-7.62M
Net income from continuing operations
30.08%-21.09M
39.29%-4.72M
37.02%-4.57M
30.89%-4.94M
14.11%-6.86M
11.57%-30.16M
-4.80%-7.77M
-1.81%-7.25M
23.91%-7.14M
21.47%-7.99M
Operating gains losses
----
----
--1K
--40K
---20K
----
----
----
----
----
Depreciation and amortization
-89.49%139K
-89.73%34K
-89.76%34K
-88.72%37K
-89.73%34K
-2.15%1.32M
0.61%331K
0.00%332K
-1.20%328K
-7.54%331K
Other non cash items
-2.83%1.51M
-7.20%374K
-7.11%366K
-7.24%359K
11.08%411K
14.52%1.55M
8.92%403K
23.90%394K
9.63%387K
17.09%370K
Change In working capital
-225.56%-1.59M
14.40%286K
-22.22%469K
-1,850.59%-1.49M
39.80%-859K
88.71%-489K
162.50%250K
-38.41%603K
104.96%85K
55.32%-1.43M
-Change in prepaid assets
-64.99%243K
-50.92%266K
-33.40%331K
-77.36%84K
38.83%-438K
801.01%694K
60.83%542K
5.07%497K
-44.71%371K
54.68%-716K
-Change in payables and accrued expense
152.36%233K
118.03%77K
244.86%1.38M
-222.13%-2.33M
262.42%1.11M
80.91%-445K
45.33%-427K
-15.29%399K
68.05%-723K
26.45%306K
-Change in other current assets
-67.21%80K
--178K
-306.56%-126K
-122.83%-29K
1.79%57K
1,009.09%244K
--0
245.24%61K
60.76%127K
800.00%56K
-Change in other current liabilities
3.76%-1.59M
4.32%-399K
17.52%-386K
4.07%-377K
-14.59%-424K
-29.56%-1.65M
-13.93%-417K
-55.48%-468K
-17.66%-393K
-36.53%-370K
-Change in other working capital
-184.38%-562K
-70.29%164K
----
----
-65.43%-1.16M
202.46%666K
32.37%552K
27.78%483K
153.03%334K
55.42%-703K
Cash from discontinued investing activities
Operating cash flow
17.09%-20.45M
33.29%-3.86M
34.44%-3.59M
-2.02%-5.91M
6.85%-7.09M
22.96%-24.67M
6.02%-5.79M
-17.36%-5.47M
38.79%-5.79M
35.11%-7.62M
Investing cash flow
Cash flow from continuing investing activities
-11.89%19.77M
166.04%2.08M
-86.50%1.74M
26.78%8.76M
24.63%7.19M
-41.58%22.44M
-138.14%-3.15M
55.37%12.91M
-64.63%6.91M
149.57%5.77M
Net PPE purchase and sale
260.27%234K
--0
--0
277.98%194K
208.11%40K
-942.86%-146K
--0
--0
-185.16%-109K
73.94%-37K
Net investment purchase and sale
-13.50%19.54M
166.04%2.08M
-86.50%1.74M
22.05%8.56M
23.14%7.15M
-41.22%22.59M
-138.14%-3.15M
55.37%12.91M
-63.83%7.02M
136.63%5.81M
Cash from discontinued investing activities
Investing cash flow
-11.89%19.77M
166.04%2.08M
-86.50%1.74M
26.78%8.76M
24.63%7.19M
-41.58%22.44M
-138.14%-3.15M
55.37%12.91M
-64.63%6.91M
149.57%5.77M
Financing cash flow
Cash flow from continuing financing activities
18.04%-645K
42.78%-111K
25.49%-152K
6.67%-168K
-2.39%-214K
92.96%-787K
54.99%-194K
91.95%-204K
97.73%-180K
20.23%-209K
Net issuance payments of debt
20.10%-648K
45.41%-113K
25.49%-152K
14.43%-172K
-6.03%-211K
-6.57%-811K
-5.61%-207K
-7.37%-204K
-6.35%-201K
-6.99%-199K
Net common stock issuance
---1K
--0
--0
----
----
--0
--0
--0
----
----
Proceeds from stock option exercised by employees
-79.41%7K
-84.62%2K
--0
----
----
-29.17%34K
-23.53%13K
--0
----
----
Net other financing activities
70.00%-3K
--0
--0
--0
70.00%-3K
86.84%-10K
--0
--0
--0
86.84%-10K
Cash from discontinued financing activities
Financing cash flow
18.04%-645K
42.78%-111K
25.49%-152K
6.67%-168K
-2.39%-214K
92.96%-787K
54.99%-194K
91.95%-204K
97.73%-180K
20.23%-209K
Net cash flow
Beginning cash position
-23.19%9.99M
-44.79%10.56M
5.60%12.56M
-9.85%9.88M
-23.19%9.99M
-26.88%13.01M
68.66%19.13M
16.28%11.89M
35.11%10.96M
-26.88%13.01M
Current changes in cash
56.05%-1.33M
79.27%-1.89M
-127.56%-2M
186.63%2.68M
94.31%-117K
36.94%-3.02M
-647.78%-9.14M
548.16%7.24M
-55.83%935K
78.78%-2.06M
End cash Position
-13.27%8.67M
-13.27%8.67M
-44.79%10.56M
5.60%12.56M
-9.85%9.88M
-23.19%9.99M
-23.19%9.99M
68.66%19.13M
16.28%11.89M
35.11%10.96M
Free cash flow
17.52%-20.47M
33.29%-3.86M
34.44%-3.59M
-0.41%-5.93M
7.30%-7.09M
22.94%-24.82M
6.02%-5.79M
-17.36%-5.47M
37.83%-5.9M
35.62%-7.65M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 17.09%-20.45M33.29%-3.86M34.44%-3.59M-2.02%-5.91M6.85%-7.09M22.96%-24.67M6.02%-5.79M-17.36%-5.47M38.79%-5.79M35.11%-7.62M
Net income from continuing operations 30.08%-21.09M39.29%-4.72M37.02%-4.57M30.89%-4.94M14.11%-6.86M11.57%-30.16M-4.80%-7.77M-1.81%-7.25M23.91%-7.14M21.47%-7.99M
Operating gains losses ----------1K--40K---20K--------------------
Depreciation and amortization -89.49%139K-89.73%34K-89.76%34K-88.72%37K-89.73%34K-2.15%1.32M0.61%331K0.00%332K-1.20%328K-7.54%331K
Other non cash items -2.83%1.51M-7.20%374K-7.11%366K-7.24%359K11.08%411K14.52%1.55M8.92%403K23.90%394K9.63%387K17.09%370K
Change In working capital -225.56%-1.59M14.40%286K-22.22%469K-1,850.59%-1.49M39.80%-859K88.71%-489K162.50%250K-38.41%603K104.96%85K55.32%-1.43M
-Change in prepaid assets -64.99%243K-50.92%266K-33.40%331K-77.36%84K38.83%-438K801.01%694K60.83%542K5.07%497K-44.71%371K54.68%-716K
-Change in payables and accrued expense 152.36%233K118.03%77K244.86%1.38M-222.13%-2.33M262.42%1.11M80.91%-445K45.33%-427K-15.29%399K68.05%-723K26.45%306K
-Change in other current assets -67.21%80K--178K-306.56%-126K-122.83%-29K1.79%57K1,009.09%244K--0245.24%61K60.76%127K800.00%56K
-Change in other current liabilities 3.76%-1.59M4.32%-399K17.52%-386K4.07%-377K-14.59%-424K-29.56%-1.65M-13.93%-417K-55.48%-468K-17.66%-393K-36.53%-370K
-Change in other working capital -184.38%-562K-70.29%164K---------65.43%-1.16M202.46%666K32.37%552K27.78%483K153.03%334K55.42%-703K
Cash from discontinued investing activities
Operating cash flow 17.09%-20.45M33.29%-3.86M34.44%-3.59M-2.02%-5.91M6.85%-7.09M22.96%-24.67M6.02%-5.79M-17.36%-5.47M38.79%-5.79M35.11%-7.62M
Investing cash flow
Cash flow from continuing investing activities -11.89%19.77M166.04%2.08M-86.50%1.74M26.78%8.76M24.63%7.19M-41.58%22.44M-138.14%-3.15M55.37%12.91M-64.63%6.91M149.57%5.77M
Net PPE purchase and sale 260.27%234K--0--0277.98%194K208.11%40K-942.86%-146K--0--0-185.16%-109K73.94%-37K
Net investment purchase and sale -13.50%19.54M166.04%2.08M-86.50%1.74M22.05%8.56M23.14%7.15M-41.22%22.59M-138.14%-3.15M55.37%12.91M-63.83%7.02M136.63%5.81M
Cash from discontinued investing activities
Investing cash flow -11.89%19.77M166.04%2.08M-86.50%1.74M26.78%8.76M24.63%7.19M-41.58%22.44M-138.14%-3.15M55.37%12.91M-64.63%6.91M149.57%5.77M
Financing cash flow
Cash flow from continuing financing activities 18.04%-645K42.78%-111K25.49%-152K6.67%-168K-2.39%-214K92.96%-787K54.99%-194K91.95%-204K97.73%-180K20.23%-209K
Net issuance payments of debt 20.10%-648K45.41%-113K25.49%-152K14.43%-172K-6.03%-211K-6.57%-811K-5.61%-207K-7.37%-204K-6.35%-201K-6.99%-199K
Net common stock issuance ---1K--0--0----------0--0--0--------
Proceeds from stock option exercised by employees -79.41%7K-84.62%2K--0---------29.17%34K-23.53%13K--0--------
Net other financing activities 70.00%-3K--0--0--070.00%-3K86.84%-10K--0--0--086.84%-10K
Cash from discontinued financing activities
Financing cash flow 18.04%-645K42.78%-111K25.49%-152K6.67%-168K-2.39%-214K92.96%-787K54.99%-194K91.95%-204K97.73%-180K20.23%-209K
Net cash flow
Beginning cash position -23.19%9.99M-44.79%10.56M5.60%12.56M-9.85%9.88M-23.19%9.99M-26.88%13.01M68.66%19.13M16.28%11.89M35.11%10.96M-26.88%13.01M
Current changes in cash 56.05%-1.33M79.27%-1.89M-127.56%-2M186.63%2.68M94.31%-117K36.94%-3.02M-647.78%-9.14M548.16%7.24M-55.83%935K78.78%-2.06M
End cash Position -13.27%8.67M-13.27%8.67M-44.79%10.56M5.60%12.56M-9.85%9.88M-23.19%9.99M-23.19%9.99M68.66%19.13M16.28%11.89M35.11%10.96M
Free cash flow 17.52%-20.47M33.29%-3.86M34.44%-3.59M-0.41%-5.93M7.30%-7.09M22.94%-24.82M6.02%-5.79M-17.36%-5.47M37.83%-5.9M35.62%-7.65M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +14.09%
Sample Name
Sample Code
 +3.93%
Sample Name
Sample Code
 +2.06%
4
United States Oil Fund LP
USO
-1.12%
5
United States Gasoline Fund Lp
UGA
-2.10%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +22.28%
Sample Name
Sample Code
 +20.52%
Sample Name
Sample Code
 +19.71%
4
Zai Lab
ZLAB
+16.97%
5
Legend Biotech
LEGN
+16.57%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On April 17, the Iranian foreign minister announced the opening of the Strait of Hormuz to merchant ships, and Trump immediately posted a me Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -